Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Chinook Therapeutics, Inc. (ADRO)
since 2015 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Chinook Therapeutics, Inc..
(See page 1 of this report.) Table 2 shows the detailed insider transactions.
This company's CIK number is 1435049.
Total stock buying since 2015: $32,811,843.
Total stock sales since 2015: $104,973,572.
Total stock option exercises since 2015: $2,200,602.
Table 3. Detailed insider trading at Chinook Therapeutics, Inc. (ADRO) , Part 2
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2018-02-26 | Van Elsas Andrea (Chief Scientific Officer) | Sale | 6,874 | 6.48 | 44,522 |
| 2018-01-25 | Schafer Gregory W (Chief Operating Officer) | Option Ex | 60,000 | .82 | 49,200 |
| 2018-01-05 | Isaacs Stephen T (President and CEO) | Sale | 7,949 | 7.95 | 63,194 |
| 2018-01-05 | Isaacs Stephen T (President and CEO) | Option Ex | 7,949 | .45 | 3,577 |
| 2018-01-02 | Schafer Gregory W (Chief Operating Officer) | Sale | 20,000 | 7.61 | 152,140 |
| 2018-01-02 | Schafer Gregory W (Chief Operating Officer) | Option Ex | 20,000 | 1.14 | 22,700 |
| 2017-12-29 | Brockstedt Dirk G. (EVP of Research and Dev.) | Option Ex | 52,000 | 1.45 | 75,400 |
| 2017-12-29 | Schafer Gregory W (Chief Operating Officer) | Option Ex | 42,000 | .82 | 34,440 |
| 2017-12-18 | Templeman Blaine (Executive VP, General Counsel) | Sale | 2,884 | 8.25 | 23,793 |
| 2017-12-15 | Brockstedt Dirk G. (EVP of Research and Dev.) | Sale | 65,223 | 8.11 | 529,219 |
| 2017-12-15 | Brockstedt Dirk G. (EVP of Research and Dev.) | Option Ex | 64,108 | 1.45 | 92,956 |
| 2017-12-01 | Brockstedt Dirk G. (EVP of Research and Dev.) | Sale | 10,000 | 9.40 | 94,000 |
| 2017-12-01 | Brockstedt Dirk G. (EVP of Research and Dev.) | Option Ex | 10,000 | .52 | 5,200 |
| 2017-12-01 | Lew Jennifer (Sr. Vice President of Finance) | Sale | 6,600 | 9.46 | 62,436 |
| 2017-12-01 | Lew Jennifer (Sr. Vice President of Finance) | Option Ex | 6,600 | .82 | 5,412 |
| 2017-12-01 | Isaacs Stephen T (President and CEO) | Sale | 40,000 | 9.38 | 375,040 |
| 2017-12-01 | Isaacs Stephen T (President and CEO) | Option Ex | 40,000 | .45 | 18,000 |
| 2017-12-01 | Schafer Gregory W (Chief Operating Officer) | Sale | 20,000 | 9.34 | 186,880 |
| 2017-12-01 | Schafer Gregory W (Chief Operating Officer) | Option Ex | 20,000 | 1.14 | 22,700 |
| 2017-11-17 | Templeman Blaine (Executive VP, General Counsel) | Sale | 243 | 8.85 | 2,150 |
| 2017-11-15 | Lew Jennifer (Sr. Vice President of Finance) | Sale | 6,600 | 8.95 | 59,069 |
| 2017-11-15 | Lew Jennifer (Sr. Vice President of Finance) | Option Ex | 6,600 | .82 | 5,412 |
| 2017-11-13 | Brockstedt Dirk G. (EVP of Research and Dev.) | Sale | 4,062 | 8.00 | 32,496 |
| 2017-11-13 | Brockstedt Dirk G. (EVP of Research and Dev.) | Option Ex | 4,062 | .52 | 2,112 |
| 2017-11-13 | Isaacs Stephen T (President and CEO) | Sale | 3,400 | 8.00 | 27,213 |
| 2017-11-13 | Isaacs Stephen T (President and CEO) | Option Ex | 3,400 | .45 | 1,530 |
| 2017-11-10 | Brockstedt Dirk G. (EVP of Research and Dev.) | Sale | 1,815 | 8.01 | 14,543 |
| 2017-11-10 | Brockstedt Dirk G. (EVP of Research and Dev.) | Option Ex | 1,815 | .52 | 943 |
| 2017-11-10 | Isaacs Stephen T (President and CEO) | Sale | 16,400 | 7.96 | 130,511 |
| 2017-11-10 | Isaacs Stephen T (President and CEO) | Option Ex | 16,400 | .45 | 7,380 |
| 2017-11-07 | Isaacs Stephen T (President and CEO) | Sale | 3,800 | 7.95 | 30,221 |
| 2017-11-07 | Isaacs Stephen T (President and CEO) | Option Ex | 3,800 | .45 | 1,710 |
| 2017-11-06 | Brockstedt Dirk G. (EVP of Research and Dev.) | Sale | 4,123 | 8.04 | 33,132 |
| 2017-11-06 | Brockstedt Dirk G. (EVP of Research and Dev.) | Option Ex | 4,123 | .52 | 2,143 |
| 2017-11-06 | Isaacs Stephen T (President and CEO) | Sale | 16,400 | 7.98 | 130,937 |
| 2017-11-06 | Isaacs Stephen T (President and CEO) | Option Ex | 16,400 | .45 | 7,380 |
| 2017-11-06 | Schafer Gregory W (Chief Operating Officer) | Sale | 20,000 | 7.97 | 159,320 |
| 2017-11-06 | Schafer Gregory W (Chief Operating Officer) | Option Ex | 20,000 | 1.14 | 22,700 |
| 2017-10-02 | Brockstedt Dirk G. (EVP of Research and Dev.) | Sale | 10,000 | 10.59 | 105,870 |
| 2017-10-02 | Brockstedt Dirk G. (EVP of Research and Dev.) | Option Ex | 10,000 | .52 | 5,200 |
| 2017-10-02 | Lew Jennifer (Sr. Vice President of Finance) | Sale | 6,600 | 10.61 | 69,993 |
| 2017-10-02 | Lew Jennifer (Sr. Vice President of Finance) | Option Ex | 6,600 | .82 | 5,412 |
| 2017-10-02 | Isaacs Stephen T (President and CEO) | Sale | 40,000 | 10.78 | 431,040 |
| 2017-10-02 | Isaacs Stephen T (President and CEO) | Option Ex | 40,000 | .45 | 18,000 |
| 2017-10-02 | Schafer Gregory W (Chief Operating Officer) | Sale | 20,000 | 10.75 | 215,060 |
| 2017-10-02 | Schafer Gregory W (Chief Operating Officer) | Option Ex | 20,000 | 1.14 | 22,700 |
| 2017-09-18 | Templeman Blaine (Executive VP, General Counsel) | Sale | 2,884 | 11.20 | 32,300 |
| 2017-09-13 | Van Elsas Andrea (Chief Scientific Officer) | Sale | 4,922 | 10.99 | 54,073 |
| 2017-09-13 | Templeman Blaine (Executive VP, General Counsel) | Sale | 3,557 | 10.99 | 39,077 |
| 2017-09-13 | Brockstedt Dirk G. (EVP of Research and Dev.) | Sale | 3,557 | 10.99 | 39,077 |
| 2017-09-13 | Lew Jennifer (Sr. Vice President of Finance) | Sale | 3,557 | 10.99 | 39,077 |
| 2017-09-13 | Isaacs Stephen T (President and CEO) | Sale | 12,204 | 10.99 | 134,073 |
| 2017-09-13 | Schafer Gregory W (Chief Operating Officer) | Sale | 4,859 | 10.99 | 53,380 |
| 2017-09-01 | Sacks Natalie (Chief Medical Officer) | Sale | 4,885 | 11.71 | 57,198 |
| 2017-09-01 | Brockstedt Dirk G. (EVP of Research and Dev.) | Sale | 10,000 | 11.70 | 116,950 |
| 2017-09-01 | Brockstedt Dirk G. (EVP of Research and Dev.) | Option Ex | 10,000 | .52 | 5,200 |
| 2017-09-01 | Lew Jennifer (Sr. Vice President of Finance) | Sale | 6,600 | 11.70 | 77,239 |
| 2017-09-01 | Lew Jennifer (Sr. Vice President of Finance) | Option Ex | 6,600 | .82 | 5,412 |
| 2017-09-01 | Isaacs Stephen T (President and CEO) | Sale | 40,000 | 11.71 | 468,600 |
| 2017-09-01 | Isaacs Stephen T (President and CEO) | Option Ex | 40,000 | .45 | 18,000 |
| 2017-09-01 | Schafer Gregory W (Chief Operating Officer) | Sale | 20,000 | 11.70 | 233,980 |
| 2017-09-01 | Schafer Gregory W (Chief Operating Officer) | Option Ex | 20,000 | 1.23 | 24,500 |
| 2017-08-11 | Dubensky Thomas W. (Chief Scientific Officer) | Sale | 9,088 | 11.17 | 101,540 |
| 2017-08-11 | Dubensky Thomas W. (Chief Scientific Officer) | Option Ex | 9,088 | 1.00 | 9,088 |
| 2017-08-10 | Dubensky Thomas W. (Chief Scientific Officer) | Sale | 40,912 | 11.43 | 467,665 |
| 2017-08-10 | Dubensky Thomas W. (Chief Scientific Officer) | Option Ex | 40,912 | 1.00 | 40,912 |
| 2017-08-08 | Schafer Gregory W (Chief Operating Officer) | Sale | 14,189 | 12.16 | 172,552 |
| 2017-08-08 | Schafer Gregory W (Chief Operating Officer) | Option Ex | 14,189 | 1.23 | 17,381 |
| 2017-08-07 | Brockstedt Dirk G. (EVP of Research and Dev.) | Sale | 10,000 | 12.18 | 121,800 |
| 2017-08-07 | Brockstedt Dirk G. (EVP of Research and Dev.) | Option Ex | 10,000 | .52 | 5,200 |
| 2017-08-07 | Lew Jennifer (Sr. Vice President of Finance) | Sale | 6,600 | 12.16 | 80,289 |
| 2017-08-07 | Lew Jennifer (Sr. Vice President of Finance) | Option Ex | 6,600 | .82 | 5,412 |
| 2017-08-07 | Isaacs Stephen T (President and CEO) | Sale | 40,000 | 12.19 | 487,560 |
| 2017-08-07 | Isaacs Stephen T (President and CEO) | Option Ex | 40,000 | .45 | 18,000 |
| 2017-08-07 | Schafer Gregory W (Chief Operating Officer) | Sale | 25,811 | 12.17 | 314,223 |
| 2017-08-07 | Schafer Gregory W (Chief Operating Officer) | Option Ex | 25,811 | 1.23 | 31,618 |
| 2017-07-06 | Dubensky Thomas W. (Chief Scientific Officer) | Sale | 4,512 | 11.23 | 50,674 |
| 2017-07-06 | Dubensky Thomas W. (Chief Scientific Officer) | Option Ex | 4,512 | .52 | 2,346 |
| 2017-07-05 | Dubensky Thomas W. (Chief Scientific Officer) | Sale | 33,688 | 11.46 | 385,929 |
| 2017-07-05 | Dubensky Thomas W. (Chief Scientific Officer) | Option Ex | 33,688 | .52 | 17,517 |
| 2017-07-05 | Isaacs Stephen T (President and CEO) | Sale | 1,341 | 11.01 | 14,763 |
| 2017-07-03 | Brockstedt Dirk G. (EVP of Research and Dev.) | Sale | 10,000 | 11.02 | 110,170 |
| 2017-07-03 | Brockstedt Dirk G. (EVP of Research and Dev.) | Option Ex | 10,000 | .47 | 4,730 |
| 2017-07-03 | Dubensky Thomas W. (Chief Scientific Officer) | Sale | 11,800 | 11.02 | 130,024 |
| 2017-07-03 | Dubensky Thomas W. (Chief Scientific Officer) | Option Ex | 11,800 | .52 | 6,136 |
| 2017-07-03 | Lew Jennifer (Sr. Vice President of Finance) | Sale | 12,000 | 11.14 | 133,632 |
| 2017-07-03 | Lew Jennifer (Sr. Vice President of Finance) | Option Ex | 12,000 | .82 | 9,840 |
| 2017-07-03 | Isaacs Stephen T (President and CEO) | Sale | 38,659 | 11.06 | 427,645 |
| 2017-07-03 | Isaacs Stephen T (President and CEO) | Option Ex | 40,000 | .48 | 19,400 |
| 2017-06-28 | Lew Jennifer (Sr. Vice President of Finance) | Sale | 12,000 | 11.19 | 134,232 |
| 2017-06-28 | Lew Jennifer (Sr. Vice President of Finance) | Option Ex | 12,000 | .82 | 9,840 |
| 2017-06-28 | Schafer Gregory W (Chief Operating Officer) | Sale | 40,000 | 11.26 | 450,560 |
| 2017-06-28 | Schafer Gregory W (Chief Operating Officer) | Option Ex | 40,000 | 1.45 | 58,000 |
| 2017-06-19 | Isaacs Stephen T (President and CEO) | Sale | 40,000 | 10.50 | 420,160 |
| 2017-06-19 | Isaacs Stephen T (President and CEO) | Option Ex | 40,000 | .52 | 20,800 |
| 2017-06-05 | Dubensky Thomas W. (Chief Scientific Officer) | Sale | 17,577 | 9.99 | 175,629 |
| 2017-06-05 | Dubensky Thomas W. (Chief Scientific Officer) | Option Ex | 17,577 | .52 | 9,140 |
| 2017-06-02 | Dubensky Thomas W. (Chief Scientific Officer) | Sale | 48,753 | 10.10 | 492,307 |
| 2017-06-02 | Dubensky Thomas W. (Chief Scientific Officer) | Option Ex | 48,753 | .52 | 25,351 |
| 2017-06-01 | Brockstedt Dirk G. (EVP of Research and Dev.) | Sale | 8,000 | 10.00 | 80,024 |
| 2017-06-01 | Brockstedt Dirk G. (EVP of Research and Dev.) | Option Ex | 8,000 | .52 | 4,160 |
| 2017-06-01 | Dubensky Thomas W. (Chief Scientific Officer) | Sale | 77,971 | 10.00 | 779,865 |
| 2017-06-01 | Dubensky Thomas W. (Chief Scientific Officer) | Option Ex | 77,971 | .52 | 40,544 |
| 2017-05-17 | Templeman Blaine (Executive VP, General Counsel) | Sale | 1,648 | 9.65 | 15,903 |
| 2017-05-17 | Brockstedt Dirk G. (EVP of Research and Dev.) | Sale | 1,011 | 9.65 | 9,756 |
| 2017-05-16 | Isaacs Stephen T (President and CEO) | Sale | 16,673 | 10.00 | 166,796 |
| 2017-05-16 | Isaacs Stephen T (President and CEO) | Option Ex | 16,673 | .52 | 8,669 |
| 2017-05-15 | Isaacs Stephen T (President and CEO) | Sale | 10,600 | 10.02 | 106,159 |
| 2017-05-15 | Isaacs Stephen T (President and CEO) | Option Ex | 10,600 | .52 | 5,512 |
| 2017-05-12 | Dubensky Thomas W. (Chief Scientific Officer) | Sale | 4,299 | 9.92 | 42,658 |
| 2017-05-12 | Dubensky Thomas W. (Chief Scientific Officer) | Option Ex | 4,299 | .52 | 2,235 |
| 2017-05-11 | Brockstedt Dirk G. (EVP of Research and Dev.) | Sale | 8,000 | 9.72 | 77,728 |
| 2017-05-11 | Brockstedt Dirk G. (EVP of Research and Dev.) | Option Ex | 8,000 | .52 | 4,160 |
| 2017-05-11 | Dubensky Thomas W. (Chief Scientific Officer) | Sale | 1,400 | 9.91 | 13,869 |
| 2017-05-11 | Dubensky Thomas W. (Chief Scientific Officer) | Option Ex | 1,400 | .52 | 728 |
| 2017-04-03 | Brockstedt Dirk G. (EVP of Research and Dev.) | Sale | 8,000 | 10.71 | 85,648 |
| 2017-04-03 | Brockstedt Dirk G. (EVP of Research and Dev.) | Option Ex | 8,000 | .45 | 3,600 |
| 2017-04-03 | Isaacs Stephen T (President and CEO) | Sale | 27,273 | 10.28 | 280,420 |
| 2017-04-03 | Isaacs Stephen T (President and CEO) | Option Ex | 27,273 | .52 | 14,181 |
| 2017-03-13 | Isaacs Stephen T (President and CEO) | Sale | 27,273 | 11.35 | 309,439 |
| 2017-03-13 | Isaacs Stephen T (President and CEO) | Option Ex | 27,273 | .52 | 14,181 |
| 2017-03-09 | Brockstedt Dirk G. (EVP of Research and Dev.) | Sale | 8,000 | 11.00 | 88,000 |
| 2017-03-09 | Brockstedt Dirk G. (EVP of Research and Dev.) | Option Ex | 8,000 | .45 | 3,600 |
| 2017-03-09 | Dubensky Thomas W. (Chief Scientific Officer) | Sale | 25,000 | 10.96 | 274,075 |
| 2017-03-09 | Dubensky Thomas W. (Chief Scientific Officer) | Option Ex | 25,000 | .83 | 20,750 |
| 2017-01-17 | Brockstedt Dirk G. (EVP of Research and Dev.) | Sale | 8,000 | 11.86 | 94,856 |
| 2017-01-17 | Brockstedt Dirk G. (EVP of Research and Dev.) | Option Ex | 8,000 | .45 | 3,600 |
| 2017-01-11 | Templeman Blaine (Executive VP, General Counsel) | Sale | 3,785 | 11.95 | 45,230 |
| 2017-01-03 | Dubensky Thomas W. (Chief Scientific Officer) | Sale | 25,000 | 11.16 | 279,000 |
| 2017-01-03 | Dubensky Thomas W. (Chief Scientific Officer) | Option Ex | 25,000 | .52 | 13,000 |
| 2017-01-03 | Isaacs Stephen T (President and CEO) | Sale | 27,273 | 11.12 | 303,303 |
| 2017-01-03 | Isaacs Stephen T (President and CEO) | Option Ex | 27,273 | .52 | 14,181 |
| 2016-12-23 | Schafer Gregory W (Chief Operating Officer) | Option Ex | 35,000 | .82 | 28,700 |
| 2016-12-01 | Dubensky Thomas W. (Chief Scientific Officer) | Sale | 50,000 | 10.94 | 547,000 |
| 2016-12-01 | Dubensky Thomas W. (Chief Scientific Officer) | Option Ex | 50,000 | .83 | 41,500 |
| 2016-12-01 | Isaacs Stephen T (President and CEO) | Sale | 54,546 | 11.20 | 610,642 |
| 2016-12-01 | Isaacs Stephen T (President and CEO) | Option Ex | 54,546 | .52 | 28,362 |
| 2016-11-14 | Haghighat Ross (Director) | Sale | 7,088 | 15.50 | 109,864 |
| 2016-11-14 | Isaacs Stephen T (President and CEO) | Sale | 27,273 | 15.26 | 416,049 |
| 2016-11-14 | Isaacs Stephen T (President and CEO) | Option Ex | 27,273 | .52 | 14,181 |
| 2016-11-11 | Schafer Gregory W (Chief Operating Officer) | Sale | 30,144 | 14.86 | 448,030 |
| 2016-11-11 | Schafer Gregory W (Chief Operating Officer) | Option Ex | 30,144 | 1.45 | 43,708 |
| 2016-11-10 | Dubensky Thomas W. (Chief Scientific Officer) | Sale | 25,000 | 14.78 | 369,400 |
| 2016-11-10 | Dubensky Thomas W. (Chief Scientific Officer) | Option Ex | 25,000 | .98 | 24,625 |
| 2016-11-10 | Lew Jennifer (Sr. Vice President of Finance) | Sale | 10,910 | 14.95 | 163,104 |
| 2016-11-10 | Lew Jennifer (Sr. Vice President of Finance) | Option Ex | 10,910 | .82 | 8,946 |
| 2016-11-10 | Schafer Gregory W (Chief Operating Officer) | Sale | 49,856 | 14.74 | 734,678 |
| 2016-11-10 | Schafer Gregory W (Chief Operating Officer) | Option Ex | 49,856 | 1.45 | 72,291 |
| 2016-10-03 | Dubensky Thomas W. (Chief Scientific Officer) | Sale | 25,000 | 12.68 | 316,900 |
| 2016-10-03 | Dubensky Thomas W. (Chief Scientific Officer) | Option Ex | 25,000 | .98 | 24,625 |
| 2016-10-03 | Isaacs Stephen T (President and CEO) | Sale | 27,273 | 12.67 | 345,521 |
| 2016-10-03 | Isaacs Stephen T (President and CEO) | Option Ex | 27,273 | .52 | 14,181 |
| 2016-09-19 | Lew Jennifer (Sr. Vice President of Finance) | Sale | 6,360 | 14.95 | 95,082 |
| 2016-09-19 | Lew Jennifer (Sr. Vice President of Finance) | Option Ex | 5,455 | .82 | 4,473 |
| 2016-09-01 | Dubensky Thomas W. (Chief Scientific Officer) | Sale | 25,000 | 14.03 | 350,775 |
| 2016-09-01 | Dubensky Thomas W. (Chief Scientific Officer) | Option Ex | 25,000 | .98 | 24,625 |
| 2016-08-11 | Dubensky Thomas W. (Chief Scientific Officer) | Sale | 25,000 | 15.18 | 379,500 |
| 2016-08-11 | Dubensky Thomas W. (Chief Scientific Officer) | Option Ex | 25,000 | .98 | 24,625 |
| 2016-07-05 | Dubensky Thomas W. (Chief Scientific Officer) | Sale | 25,000 | 11.61 | 290,250 |
| 2016-07-05 | Dubensky Thomas W. (Chief Scientific Officer) | Option Ex | 25,000 | .98 | 24,625 |
| 2016-05-16 | Brockstedt Dirk G. (Sr. VP of Research and Dev.) | Sale | 905 | 8.20 | 7,420 |
| 2016-05-16 | Dubensky Thomas W. (Chief Scientific Officer) | Sale | 905 | 8.20 | 7,420 |
| 2016-05-16 | Schafer Gregory W (Chief Operating Officer) | Sale | 905 | 8.20 | 7,420 |
| 2016-01-11 | Brockstedt Dirk G. (Sr. VP of Research and Dev.) | Sale | 22,000 | 22.69 | 499,224 |
| 2016-01-11 | Brockstedt Dirk G. (Sr. VP of Research and Dev.) | Option Ex | 22,000 | .95 | 20,900 |
| 2016-01-08 | Schafer Gregory W (Chief Operating Officer) | Sale | 20,000 | 23.58 | 471,599 |
| 2016-01-08 | Schafer Gregory W (Chief Operating Officer) | Option Ex | 20,000 | 1.00 | 20,000 |
| 2016-01-06 | Lew Jennifer (Sr. Vice President of Finance) | Sale | 5,242 | 25.86 | 135,584 |
| 2016-01-06 | Lew Jennifer (Sr. Vice President of Finance) | Option Ex | 5,242 | .82 | 4,298 |
| 2016-01-05 | Isaacs Stephen T (President and CEO) | Sale | 12,500 | 26.52 | 331,562 |
| 2016-01-05 | Isaacs Stephen T (President and CEO) | Option Ex | 12,500 | .52 | 6,500 |
| 2016-01-04 | Dubensky Thomas W. (Chief Scientific Officer) | Sale | 15,000 | 26.59 | 398,775 |
| 2016-01-04 | Dubensky Thomas W. (Chief Scientific Officer) | Option Ex | 15,000 | 4.45 | 66,750 |
| 2016-01-04 | Isaacs Stephen T (President and CEO) | Sale | 12,500 | 26.73 | 334,125 |
| 2016-01-04 | Isaacs Stephen T (President and CEO) | Option Ex | 12,500 | .52 | 6,500 |
| 2015-12-31 | Isaacs Stephen T (President and CEO) | Option Ex | 10,000 | .45 | 4,500 |
| 2015-12-29 | Lew Jennifer (Sr. Vice President of Finance) | Option Ex | 4,200 | .82 | 3,444 |
| 2015-12-24 | Schafer Gregory W (Chief Operating Officer) | Option Ex | 15,000 | .82 | 12,300 |
| 2015-12-16 | Brockstedt Dirk G. (Sr. VP of Research and Dev.) | Option Ex | 12,000 | 1.45 | 17,400 |
| 2015-12-10 | Brockstedt Dirk G. (Sr. VP of Research and Dev.) | Sale | 25,000 | 29.75 | 743,750 |
| 2015-12-10 | Brockstedt Dirk G. (Sr. VP of Research and Dev.) | Option Ex | 25,000 | 1.45 | 36,250 |
| 2015-12-07 | Schafer Gregory W (Chief Operating Officer) | Sale | 25,000 | 29.80 | 745,125 |
| 2015-12-07 | Schafer Gregory W (Chief Operating Officer) | Option Ex | 25,000 | 1.45 | 36,250 |
| 2015-12-03 | Lew Jennifer (Sr. Vice President of Finance) | Sale | 5,242 | 30.16 | 158,124 |
| 2015-12-03 | Lew Jennifer (Sr. Vice President of Finance) | Option Ex | 5,242 | .82 | 4,298 |
| 2015-12-01 | Dubensky Thomas W. (Chief Scientific Officer) | Sale | 30,000 | 29.66 | 889,740 |
| 2015-12-01 | Dubensky Thomas W. (Chief Scientific Officer) | Option Ex | 30,000 | 3.12 | 93,510 |
| 2015-12-01 | Isaacs Stephen T (President and CEO) | Sale | 25,000 | 29.46 | 736,625 |
| 2015-12-01 | Isaacs Stephen T (President and CEO) | Option Ex | 25,000 | .52 | 13,000 |
| 2015-11-30 | Greenman William Mariner (Director) | Sale | 3,000 | 30.65 | 91,950 |
| 2015-11-18 | Lew Jennifer (Sr. Vice President of Finance) | Sale | 6,712 | 28.52 | 191,426 |
| 2015-11-18 | Lew Jennifer (Sr. Vice President of Finance) | Option Ex | 5,242 | .82 | 4,298 |
| 2015-11-17 | Brockstedt Dirk G. (Sr. VP of Research and Dev.) | Sale | 19,047 | 28.27 | 538,458 |
| 2015-11-17 | Brockstedt Dirk G. (Sr. VP of Research and Dev.) | Option Ex | 19,047 | .70 | 13,332 |
| 2015-11-17 | Dubensky Thomas W. (Chief Scientific Officer) | Sale | 20,519 | 28.23 | 579,148 |
| 2015-11-17 | Dubensky Thomas W. (Chief Scientific Officer) | Option Ex | 20,519 | 1.45 | 29,752 |
| 2015-11-17 | Schafer Gregory W (Chief Operating Officer) | Sale | 15,178 | 28.31 | 429,689 |
| 2015-11-17 | Schafer Gregory W (Chief Operating Officer) | Option Ex | 15,178 | 1.45 | 22,008 |
| 2015-11-16 | Brockstedt Dirk G. (Sr. VP of Research and Dev.) | Sale | 7,423 | 27.55 | 204,540 |
| 2015-11-16 | Brockstedt Dirk G. (Sr. VP of Research and Dev.) | Option Ex | 5,953 | .45 | 2,678 |
| 2015-11-16 | Dubensky Thomas W. (Chief Scientific Officer) | Sale | 10,951 | 27.78 | 304,185 |
| 2015-11-16 | Dubensky Thomas W. (Chief Scientific Officer) | Option Ex | 9,481 | 1.45 | 13,747 |
| 2015-11-16 | Isaacs Stephen T (President and CEO) | Sale | 25,000 | 28.01 | 700,250 |
| 2015-11-16 | Isaacs Stephen T (President and CEO) | Option Ex | 25,000 | .52 | 13,000 |
| 2015-11-16 | Schafer Gregory W (Chief Operating Officer) | Sale | 11,292 | 27.81 | 313,996 |
| 2015-11-16 | Schafer Gregory W (Chief Operating Officer) | Option Ex | 9,822 | 1.45 | 14,241 |
| 2015-04-20 | Morningside Venture (vi) Investments Ltd (10% Owner) | Buy | 441,176 | 17.00 | 7,499,992 |
| 2015-04-20 | Obrien Stephanie Monaghan (Director) | Buy | 3,400 | 17.00 | 57,800 |
| 2015-04-20 | Rogers John E. And Lois A. (10% Owner) | Buy | 164,558 | 17.00 | 2,797,486 |
| 2015-04-20 | Lew Jennifer (Sr. Vice President of Finance) | Buy | 2,000 | 17.00 | 34,000 |
| 2015-04-20 | Greenman William Mariner (Director) | Buy | 3,000 | 17.00 | 51,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
of ADRO listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Chinook Therapeutics, Inc. (symbol ADRO,
CIK number 1435049) see
the Securities and Exchange Commission (SEC) website.